Logo image of STUD.CA

STALLION URANIUM CORP (STUD.CA) Stock Fundamental Analysis

TSX-V:STUD - CA8529192087 - Common Stock

0.28 CAD
+0.05 (+19.15%)
Last: 8/26/2025, 7:00:00 PM
Fundamental Rating

2

Overall STUD gets a fundamental rating of 2 out of 10. We evaluated STUD against 211 industry peers in the Oil, Gas & Consumable Fuels industry. While STUD has a great health rating, there are worries on its profitability. STUD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year STUD has reported negative net income.
STUD had a negative operating cash flow in the past year.
In the past 5 years STUD always reported negative net income.
In the past 5 years STUD always reported negative operating cash flow.
STUD.CA Yearly Net Income VS EBIT VS OCF VS FCFSTUD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

STUD has a Return On Assets of -159.62%. This is amonst the worse of the industry: STUD underperforms 85.31% of its industry peers.
STUD's Return On Equity of -171.84% is on the low side compared to the rest of the industry. STUD is outperformed by 78.20% of its industry peers.
Industry RankSector Rank
ROA -159.62%
ROE -171.84%
ROIC N/A
ROA(3y)-61.91%
ROA(5y)-42.67%
ROE(3y)-74.25%
ROE(5y)-51.05%
ROIC(3y)N/A
ROIC(5y)N/A
STUD.CA Yearly ROA, ROE, ROICSTUD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

STUD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STUD.CA Yearly Profit, Operating, Gross MarginsSTUD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

7

2. Health

2.1 Basic Checks

STUD has more shares outstanding than it did 1 year ago.
STUD has more shares outstanding than it did 5 years ago.
There is no outstanding debt for STUD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
STUD.CA Yearly Shares OutstandingSTUD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
STUD.CA Yearly Total Debt VS Total AssetsSTUD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 5.63 indicates that STUD is not in any danger for bankruptcy at the moment.
The Altman-Z score of STUD (5.63) is better than 87.68% of its industry peers.
There is no outstanding debt for STUD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.63
ROIC/WACCN/A
WACCN/A
STUD.CA Yearly LT Debt VS Equity VS FCFSTUD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.32 indicates that STUD should not have too much problems paying its short term obligations.
STUD's Current ratio of 1.32 is fine compared to the rest of the industry. STUD outperforms 69.19% of its industry peers.
A Quick Ratio of 1.32 indicates that STUD should not have too much problems paying its short term obligations.
The Quick ratio of STUD (1.32) is better than 71.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.32
STUD.CA Yearly Current Assets VS Current LiabilitesSTUD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

0

3. Growth

3.1 Past

STUD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -799.41%.
EPS 1Y (TTM)-799.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%212.54%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

STUD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STUD.CA Price Earnings VS Forward Price EarningsSTUD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STUD.CA Per share dataSTUD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

STUD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STALLION URANIUM CORP

TSX-V:STUD (8/26/2025, 7:00:00 PM)

0.28

+0.05 (+19.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)08-27 2025-08-27
Inst Owners0.33%
Inst Owner ChangeN/A
Ins Owners14.33%
Ins Owner ChangeN/A
Market Cap12.78M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB 1.21
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.23
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -159.62%
ROE -171.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-61.91%
ROA(5y)-42.67%
ROE(3y)-74.25%
ROE(5y)-51.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.32
Altman-Z 5.63
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-799.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%212.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.41%
OCF growth 3YN/A
OCF growth 5YN/A